Meropenem Venus Pharma (Meropenem Anhydrous)

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections.

• Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal sepsis.
• Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis.
• Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitic pathogens.
• Severe sepsis: offers rapid bactericidal activity in systemic infection.
• Hospital‑acquired pneumonia: targets multidrug‑resistant organisms in ventilated patients.

• Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its broad spectrum includes many Gram‑negative, Gram‑positive, and anaerobic organisms, and it is resistant to most β‑lactamases.

Adverse reactions may occur with meropenem therapy.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: occasional feeling of queasiness.
• Headache: transient cranial discomfort.
• Rash: mild skin erythema.
• Elevated liver enzymes: transient increase in transaminases.
• Phlebitis at infusion site: irritation of peripheral veins.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or CNS disease.
• Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.
• Clostridioides difficile colitis: pseudomembranous colitis risk.
• Hemolytic anemia: rare immune‑mediated red cell destruction.
• Thrombocytopenia: low platelet counts.
• Renal dysfunction: acute kidney injury in susceptible individuals.

Meropenem should be used with caution in specific clinical situations.

• Renal impairment: adjust dose based on creatinine clearance.
• CNS disorders: monitor for neurotoxicity, especially seizures.
• Pregnancy and lactation: safety not established; weigh benefits against risks.
• Hypersensitivity: avoid in patients with known β‑lactam allergy.
• Concomitant valproic acid: may reduce serum levels, monitor seizure control.
• Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several medications.

Major Interactions (Avoid)

• Valproic acid: reduces valproate levels, risking loss of seizure control.
• Probenecid: decreases renal clearance, increasing meropenem exposure.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: additive nephrotoxicity; monitor renal function.
• Loop diuretics: potential for electrolyte disturbances; observe serum electrolytes.
• Anticoagulants (e.g., warfarin): may alter INR; check coagulation parameters.